Breast Cancer Drug Shows Groundbreaking Results ANDREW POLLACK Palbociclib a drug being developed by Pfizer cut in half the risk that advanced cancer would worsen among patients taking part in a Phase 2 study researchers said. April 7 2014 at 4:00AM http://nyti.ms/1oE1ChP The New York Times Business Day Drugs (Pharmaceuticals) Breast Cancer Clinical Trials

By ANDREW POLLACK via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/1oE1ChP Breast Cancer Drug Shows ‘Groundbreaking’ Results Palbociclib, a drug being developed by Pfizer, cut in half the risk that advanced cancer would worsen among patients taking part in a Phase 2 study, researchers said. April 7, 2014 at 4:00AM http://nyti.ms/1oE1ChP The New York Times Drugs (Pharmaceuticals), Breast Cancer, Clinical Trials